Bicocca Open Archive

Logo unimib boa
CHIORAZZI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.098
EU - Europa 7.589
AS - Asia 4.478
SA - Sud America 262
AF - Africa 44
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 23
Totale 24.536
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.879
SG - Singapore 1.949
IT - Italia 1.572
DE - Germania 1.362
CN - Cina 1.249
RU - Federazione Russa 1.230
SE - Svezia 976
IE - Irlanda 824
UA - Ucraina 541
HK - Hong Kong 528
GB - Regno Unito 330
BR - Brasile 225
CA - Canada 200
VN - Vietnam 197
AT - Austria 169
FI - Finlandia 149
ID - Indonesia 140
FR - Francia 133
DK - Danimarca 115
IN - India 97
JP - Giappone 77
TR - Turchia 61
NL - Olanda 56
BE - Belgio 45
KR - Corea 37
IR - Iran 34
AU - Australia 24
EU - Europa 23
MY - Malesia 20
ZA - Sudafrica 19
NZ - Nuova Zelanda 18
ES - Italia 15
PL - Polonia 13
TW - Taiwan 12
AR - Argentina 10
MX - Messico 10
CH - Svizzera 9
EG - Egitto 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
HU - Ungheria 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
BD - Bangladesh 6
EC - Ecuador 6
HR - Croazia 6
BG - Bulgaria 5
IL - Israele 5
IQ - Iraq 5
UZ - Uzbekistan 5
AL - Albania 4
CO - Colombia 4
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
NG - Nigeria 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
VE - Venezuela 4
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
MA - Marocco 3
PH - Filippine 3
PT - Portogallo 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
DZ - Algeria 2
GT - Guatemala 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
SC - Seychelles 2
AM - Armenia 1
AZ - Azerbaigian 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KW - Kuwait 1
NO - Norvegia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 24.536
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.859
Singapore 1.285
Dublin 799
Woodbridge 773
Chandler 772
Frankfurt am Main 756
Wilmington 634
Milan 589
Houston 580
Fairfield 565
Dearborn 547
Jacksonville 539
Hong Kong 491
Ashburn 482
New York 374
Santa Clara 336
Princeton 302
Nanjing 232
Seattle 231
Boardman 179
Cambridge 162
Vienna 155
Shanghai 151
Jakarta 128
Beijing 104
Dong Ket 92
Guangzhou 86
Lachine 85
Lawrence 78
Altamura 73
Council Bluffs 72
Nanchang 72
Shenyang 72
Andover 51
Carate Brianza 49
Los Angeles 49
Chicago 48
Rome 47
Helsinki 45
Moscow 44
Falls Church 43
Toronto 43
Hangzhou 41
Pune 40
Fremont 39
Jinan 39
Nuremberg 39
Ottawa 39
San Diego 38
Brussels 36
Jiaxing 35
Kunming 34
Tianjin 30
Zhengzhou 30
Changsha 29
Hebei 29
Melzo 27
Nürnberg 27
Grafing 26
Norwalk 26
Sacramento 24
Tokyo 24
London 23
Bergamo 22
Florence 22
Shangdi 22
Mountain View 20
Ningbo 20
Dallas 19
Edmonton 18
Phoenix 17
São Paulo 17
Taizhou 17
Leawood 16
Codroipo 15
Hefei 15
Hägersten 15
Lissone 15
Philadelphia 15
Washington 15
Düsseldorf 13
Lappeenranta 13
Mainz 13
Paris 13
Rio de Janeiro 13
Cagliari 12
Catania 12
Pasir Mas 12
Shinjuku 12
Bologna 11
Canazei 11
Kiev 11
Munich 11
Tehran 11
Wuhan 11
Daejeon 10
Norristown 10
Rende 10
Romola 10
Sesto San Giovanni 10
Totale 16.278
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 335
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 313
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 312
Age-related changes in the function and structure of the peripheral sensory pathway in mice 308
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 307
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 295
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 289
Artificial apolipoprotein corona enables nanoparticle brain targeting 280
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 265
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 260
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 254
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 253
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 240
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 234
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 231
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 230
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 220
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 214
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 214
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 209
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 209
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 208
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 207
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 203
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 197
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 196
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 196
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 196
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 194
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 193
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 192
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 191
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 188
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 187
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 185
OCT2 transporter involvement in development of cisplatin toxicity 185
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 183
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 182
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 179
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 179
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 177
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 177
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 174
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 174
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 172
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 172
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 171
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 171
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 170
Current view in platinum drug mechanisms of peripheral neurotoxicity 169
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 167
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 165
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 165
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 165
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 164
Lipoplatin tm: a less neurotoxic formulation of cisplatin 163
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 162
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 160
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 159
Granulocytes in actively induced Lewis rat EAE 157
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 156
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 155
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 150
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 150
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 150
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 149
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 148
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 148
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 147
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 147
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 147
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 146
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 146
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 144
Multimodal experimental approach to the study of human neurological diseases 144
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 144
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 144
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 143
MSCs effect on Dark Agouti rats affected by chronic EAE 142
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 142
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 142
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 142
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 142
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 142
Genetic factors influencing the development of vincristine-induced neurotoxicity 142
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 140
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 138
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 138
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 138
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 137
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 137
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 136
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 136
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 136
CIPN and its mechanism of development 135
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 135
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 132
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 131
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 129
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 128
Totale 18.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020621 0 0 0 0 0 0 0 0 0 319 247 55
2020/20213.424 147 132 377 353 262 306 408 321 290 258 204 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.484 389 846 380 332 259 540 63 181 277 51 104 62
2023/20242.986 97 98 101 146 386 725 508 163 158 68 68 468
2024/20256.060 452 898 712 367 624 294 512 284 899 1.018 0 0
Totale 25.980